IRONWOOD PHARMACEUTICALS INC Balance Sheet
IRWD / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
IRONWOOD PHARMACEUTICALS INC had $397M in total assets with negative shareholders' equity of $262M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $215.5M | $88.6M | $92.2M | $620.1M | $620.1M | $177.0M | $177.0M | $125.7M | $125.7M | $54.0M | $261.3M | $74.3M | $87.3M | $136.7M | $87.3M |
| Accounts Receivable | $46.7M | $81.9M | $129.1M | $115.5M | $114.0M | $122.4M | $11.3M | $21.0M | $3.2M | $933.0K | $2.9M | $10.0K | $513.0K | $457.0K | $74.0K |
| Inventory | - | - | - | - | - | - | $648.0K | - | $735.0K | $1.1M | $0 | $5.0M | $22.1M | $6.7M | - |
| Current Assets | $274.2M | $182.4M | $233.3M | $780.6M | $745.2M | $495.8M | $306.9M | $266.4M | $311.6M | $380.2M | $500.2M | $288.3M | $229.1M | $184.4M | $167.6M |
| PP&E (Net) | $3.4M | $4.5M | $5.6M | $6.3M | $7.6M | $8.9M | $12.4M | $17.3M | $17.3M | $20.5M | $21.1M | $29.8M | $37.4M | $37.5M | $33.6M |
| Goodwill | - | - | - | - | - | - | $785.0K | $785.0K | $785.0K | $785.0K | - | - | - | - | - |
| Total Assets | $396.9M | $350.9M | $471.1M | $1.1B | $1.1B | $559.2M | $402.7M | $332.1M | $605.7M | $709.8M | $619.1M | $329.3M | $279.0M | $229.9M | $209.0M |
| Current Liabilities | $242.2M | $38.8M | $276.1M | $25.5M | $161.7M | $32.2M | $40.9M | $119.5M | $66.0M | $91.1M | $76.5M | $60.5M | $41.0M | $54.9M | $65.1M |
| Total Debt | - | - | - | $396.3M | $454.2M | $430.3M | - | - | - | - | $220.6M | - | - | - | - |
| Shareholders' Equity | -$261.8M | -$301.3M | -$346.3M | $652.4M | $605.9M | -$196.4M | -$93.3M | $66.7M | $9.8M | $66.7M | $95.1M | $88.6M | $109.9M | $144.1M | $109.9M |